Exploring the Pharmaceutical View of Interactions with Medications and Psychedelics

Psychedelic healing has gained significant attention in recent years as a potential breakthrough in mental health treatment. The use of plant medicines such as psilocybin, MDMA, and ketamine has shown promising results in alleviating symptoms of depression, anxiety, and PTSD. However, as with any medication, it is crucial to understand the potential risks and interactions associated with these substances. In this episode, we will explore the insights shared by Dr. Kristen Speer and Dr. Saed Al-Olimat, co-founders of the Psychedelic Pharmacists Association, as they discuss the role of pharmacists in psychedelic therapy and the safety considerations that need to be taken into account.